Mesenchymal stem cells therapy for immune thrombocytopenia in pregnancy: a case report
This report documents the first maternal-fetal outcomes following non-standard UC-MSCs exposure in pregnancy complicated by ITP. While not medically indicated, this case highlights the reality of patient-driven use of experimental therapies and underscores the urgent need for systematic studies to evaluate maternal-fetal safety.
Authors
- Yuchun Gu (ORCID: https://orcid.org/0000-0002-7558-0447)
- Hong Gao (ORCID: https://orcid.org/0000-0002-8592-5242)
- Hui Shi (ORCID: https://orcid.org/0000-0002-3574-8807)
- Li‐Da Wu (ORCID: https://orcid.org/0000-0002-3068-6694)
- Tong Tong (ORCID: https://orcid.org/0000-0002-9988-1295)
- Na Qiao (ORCID: https://orcid.org/0000-0002-4079-2693)
- Shengjiang Tan
- Song Chen
Institutions
- Aston University (GB)
- Capital Medical University (CN)
- Peking University (CN)
- Beijing Tian Tan Hospital (CN)
- Jingdong (China) (CN)
- Beijing National Laboratory for Molecular Sciences (CN)
- Beijing Obstetrics and Gynecology Hospital (CN)
Publication Details
- Journal
- BMC Pregnancy and Childbirth
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1186/s12884-025-08177-9
- Citations
- 1
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77